Education
About Us
Working with TipRanks
Follow Us
Anthera Pharmaceuticals (ANTH)
OTHER OTC:ANTH
| Dec 17 | |
|---|---|
| Income Statement | |
| Total Revenue | $ 0.00 |
| Gross Profit | $ -281.00K |
| Operating Income | $ -36.43M |
| EBITDA | $ -26.59M |
| Net Income | $ -16.93M |
| Balance Sheet | |
| Cash & Short-Term Investments | $ 2.20M |
| Total Assets | $ 3.67M |
| Total Debt | $ 0.00 |
| Net Debt | $ -2.20M |
| Total Liabilities | $ 9.17M |
| Stockholders' Equity | $ -5.50M |
| Cash Flow | |
| Free Cash Flow | $ -36.90M |
| Operating Cash Flow | $ -36.90M |
| Investing Cash Flow | $ 0.00 |
| Financing Cash Flow | $ 18.25M |
Anthera Pharmaceuticals Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.